NCT00841113 2009-02-11
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Speciality European Pharma Limited
Phase 3 Completed
Speciality European Pharma Limited
PRAECIS Pharmaceuticals Inc.
PRAECIS Pharmaceuticals Inc.